Characterization of surgically transposed ovaries in integrated PET/CT scan in patients with cervical cancer

References

• Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000; 74: 743–8
   PubMed Web of Science ®Google Scholar
• Newbold R, Safrit H, Cooper C. Surgical lateral ovarian transposition: CT appearance. AJR Am J Roentgenol 1990; 154: 119–20
   PubMed Web of Science ®Google Scholar
• Goldberg RE, Sturgeon JF. Surgically transposed ovary presenting as an intraperitoneal mass on computed tomography. Can Assoc Radiol J 1995; 46: 229–30
   PubMed Web of Science ®Google Scholar
• Kier R, Chambers SK. Surgical transposition of the ovaries: imaging findings in 14 patients. AJR Am J Roentgenol 1989; 153: 1003–6
   PubMed Web of Science ®Google Scholar
• Bashist B, Friedman WN, Killackey MA. Surgical transposition of the ovary: radiologic appearance. Radiology 1989; 173: 857–60
   PubMed Web of Science ®Google Scholar
• Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003; 290: 3199–206
   PubMed Web of Science ®Google Scholar
• Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500–7
   PubMed Web of Science ®Google Scholar
• Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002; 225: 575–81
   PubMed Web of Science ®Google Scholar
• Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61–77; quiz 150–1.
   PubMed Web of Science ®Google Scholar
• Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999; 26: 1363–78
   PubMedGoogle Scholar
• Belinson JL, Doherty M, McDay JB. A new technique for ovarian transposition. Surg Gynecol Obstet 1984; 159: 157–60
   PubMedGoogle Scholar
• Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44: 1200–9
   PubMed Web of Science ®Google Scholar
• McCall CM, Keaty EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery. Am J Obstet Gynecol 1958; 75: 590–600; discussion -5.
   PubMed Web of Science ®Google Scholar
• Le Floch O, Donaldson SS, Kaplan HS. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer 1976; 38: 2263–8
   PubMed Web of Science ®Google Scholar
• Ray GR, Trueblood HW, Enright LP, Kaplan HS, Nelsen TS. Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology 1970; 96: 175–80
   PubMed Web of Science ®Google Scholar
• Thomas PR, Winstanly D, Peckham MJ, Austin DE, Murray MA, Jacobs HS. Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. Br J Cancer 1976; 33: 226–31
   PubMed Web of Science ®Google Scholar
• Hunter MC, Glees JP, Gazet JC. Oophoropexy and ovarian function in the treatment of Hodgkin's disease. Clin Radiol 1980; 31: 21–6
   PubMed Web of Science ®Google Scholar
• Anderson B, LaPolla J, Turner D, Chapman G, Buller R. Ovarian transposition in cervical cancer. Gynecol Oncol 1993; 49: 206–14
   PubMed Web of Science ®Google Scholar
• Chambers SK, Chambers JT, Holm C, Peschel RE, Schwartz PE. Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients. Gynecol Oncol 1990; 39: 155–9
   PubMed Web of Science ®Google Scholar
• Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol 1995; 56: 3–7
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Wakai K, Ishikawa H, Nawa A, Suzuki Y, Nakamura S, et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 2001; 82: 504–9
   PubMed Web of Science ®Google Scholar
• Yamamoto R, Okamoto K, Yukiharu T, Kaneuchi M, Negishi H, Sakuragi N, et al. A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol 2001; 82: 312–6
   PubMed Web of Science ®Google Scholar
• Ames J, Blodgett T, Meltzer C. 18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma. AJR Am J Roentgenol 2005; 185: 1057–9
   PubMed Web of Science ®Google Scholar
• Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 2005; 32: 757–63
   PubMed Web of Science ®Google Scholar
• Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging 2005; 32: 549–56
   PubMed Web of Science ®Google Scholar